Metrion Biosciences Appoints Dr Andrew Southan as Chief Executive Officer

April 8, 2019 Off By BusinessWire

CAMBRIDGE, England–(BUSINESS WIRE)–Metrion Biosciences (“Metrion”), the specialist ion channel contract
research and drug discovery company, today announced the appointment of
Dr Andrew Southan as Chief Executive Officer, with immediate effect. Dr
Southan was previously the Company’s Chief Operating Officer.

Dr Southan joined Metrion as Head of Commercial Operations in October
2016, was promoted to Chief Operating Officer in April 2017, and joined
the board as a director in March 2018. During this period the Company
has made significant progress, developing innovative, high-quality
assays for its clients and expanding the international customer base
into new territories.

Andy has over 25 years of experience in ion channel research and
development, starting his career at Wyeth Research (UK), followed by
postdoctoral studies at Imperial College London. He has also held
leadership roles at CeNeS Pharmaceuticals and Ionix Pharmaceuticals, and
spent 12 years leading and expanding the UK ion channel team for
BioFocus and Charles River Laboratories.

Keith McCullagh. Chairman of Metrion Biosciences, commented: “Andy
has been a driving force supporting Metrion’s growth and success over
the past three years. His extensive pharmaceutical CRO industry
experience, deep technical understanding of the ion channel field and
strong management skills made him the ideal candidate for this new
leadership role. I congratulate Andy on his appointment and look forward
to working with him to achieve continued progress.”

Dr Andrew Southan, Chief Executive Officer, Metrion
Biosciences, said: “It is a pleasure to work with Metrion’s team
of expert ion channel specialists, management team and board of
directors, and I am looking forward to this next chapter as CEO, further
expanding Metrion’s ion channel services as well as the Company’s
reputation as a global leader in ion channel biology.”

ENDS

For a high resolution image please contact Zyme Communications